ID   NCC-SS6-C1
AC   CVCL_E3AB
RX   PubMed=39174825;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 34 hours (PubMed=39174825).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=39174825).
CC   Derived from site: In situ; Thoracic cavity; UBERON=UBERON_0002224.
ST   Source(s): PubMed=39174825
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D21S11: 30,31
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
RX   PubMed=39174825; DOI=10.1007/s13577-024-01122-6;
RA   Osaki J., Noguchi R., Ono T., Adachi Y., Iwata S., Toda Y., Funada T.,
RA   Iwata S., Kojima N., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-SS6-C1: a novel
RT   patient-derived cell line of synovial sarcoma.";
RL   Hum. Cell 37:1734-1741(2024).
//